Aldosterone receptor antagonists: effective but often forgotten.
作者信息
Maron Bradley A, Leopold Jane A
机构信息
Brigham and Women's Hospital, Division of Cardiovascular Medicine, PBB-1, 75 Francis St, Boston, MA 02115, USA.
出版信息
Circulation. 2010 Feb 23;121(7):934-9. doi: 10.1161/CIRCULATIONAHA.109.895235.
Abstract
摘要
相似文献
1
Aldosterone receptor antagonists: effective but often forgotten.醛固酮受体拮抗剂：有效但常被遗忘。
Circulation. 2010 Feb 23;121(7):934-9. doi: 10.1161/CIRCULATIONAHA.109.895235.
2
New therapy update. Inspra (eplerenone tablets).新疗法更新。因spra（依普利酮片）。
Congest Heart Fail. 2003 Nov-Dec;9(6):341-2. doi: 10.1111/j.1527-5299.2003.03306.x.
3
Treatment considerations with aldosterone receptor antagonists.醛固酮受体拮抗剂的治疗考量
J Clin Hypertens (Greenwich). 2011 Jan;13(1):65-9. doi: 10.1111/j.1751-7176.2010.00377.x. Epub 2010 Oct 4.
4
Hypertension, angiotensin II, aldosterone, and race.高血压、血管紧张素II、醛固酮与种族
J Am Coll Cardiol. 2003 Apr 2;41(7):1156-8. doi: 10.1016/s0735-1097(03)00053-6.
5
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.难治性高血压的管理：聚焦于盐皮质激素受体拮抗剂
Vasc Health Risk Manag. 2017 Oct 16;13:403-411. doi: 10.2147/VHRM.S138599. eCollection 2017.
6
ARAs to the RESCUE.血管紧张素受体拮抗剂来救援。
J Am Soc Hypertens. 2016 Mar;10(3):187-8. doi: 10.1016/j.jash.2016.01.014.
7
Review article: eplerenone: an underused medication?综述文章：依普利酮：一种未被充分应用的药物？
J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):318-25. doi: 10.1177/1074248410371946. Epub 2010 Sep 27.
8
[Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].[心力衰竭中的选择性醛固酮阻断。依普利酮降低心肌梗死后风险]
MMW Fortschr Med. 2003 Oct 30;145(44):42-3.
9
Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction?急性心肌梗死后合并左心室功能不全时，醛固酮受体拮抗剂依普利酮是否应该使用？
Expert Opin Pharmacother. 2003 Sep;4(9):1605-7. doi: 10.1517/14656566.4.9.1605.
10
Eplerenone: cardiovascular protection.依普利酮：心血管保护作用。
Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A.
引用本文的文献
1
Physicians' Perspectives on a Best Practice Alert to Improve Guideline-Directed Medical Therapy in Heart Failure.医生对一项最佳实践警报的看法，该警报旨在改善心力衰竭的指南指导药物治疗
JACC Adv. 2025 Mar;4(3):101609. doi: 10.1016/j.jacadv.2025.101609.
2
Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy.ADAM17基因敲低与依普利酮联合使用在改善糖尿病性心肌病方面比单一治疗更有效。
Front Pharmacol. 2024 May 10;15:1364827. doi: 10.3389/fphar.2024.1364827. eCollection 2024.
3
Therapeutical Approach to Arterial Hypertension - Current State of the Art.动脉高血压的治疗方法——最新技术现状。
Curr Med Chem. 2024;31(29):4602-4620. doi: 10.2174/0109298673274823231220063652.
4
Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade.盐皮质激素受体拮抗剂在心力衰竭治疗中的作用：针对心力衰竭级联反应
Cureus. 2023 Sep 14;15(9):e45241. doi: 10.7759/cureus.45241. eCollection 2023 Sep.
5
Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases.饮食和运动在衰老、阿尔茨海默病和其他慢性疾病中的作用。
Ageing Res Rev. 2023 Nov;91:102091. doi: 10.1016/j.arr.2023.102091. Epub 2023 Oct 11.
6
Unilateral chemical ablation of the adrenal gland lowers blood pressure and alleviates target organ damage in spontaneously hypertensive rats.单侧肾上腺化学消融术可降低自发性高血压大鼠的血压并减轻靶器官损伤。
Hypertens Res. 2023 Dec;46(12):2693-2704. doi: 10.1038/s41440-023-01444-2. Epub 2023 Oct 3.
7
Nanoparticle approaches for the renin-angiotensin system.用于肾素-血管紧张素系统的纳米颗粒方法。
Heliyon. 2023 Jun 2;9(6):e16951. doi: 10.1016/j.heliyon.2023.e16951. eCollection 2023 Jun.
8
Pulmonary Hypertension: A Contemporary Review.肺动脉高压：当代综述。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):528-548. doi: 10.1164/rccm.202302-0327SO.
9
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.台湾心脏病学会与台湾高血压学会2022年高血压管理指南
Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.
10
An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers.肾素-血管紧张素-醛固酮系统（RAAS）阻滞剂的临床必需和药效学显著药物相互作用概述。
Curr Cardiol Rev. 2022;18(6):e110522204611. doi: 10.2174/1573403X18666220511152330.
本文引用的文献
1
The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.依普利酮对左心室收缩功能不全患者心肌梗死后住院时间及心力衰竭住院总天数的影响。
Am Heart J. 2009 Sep;158(3):437-43. doi: 10.1016/j.ahj.2009.07.003.
2
Hypertension and cardiac failure in its various forms.高血压及各种形式的心力衰竭。
Med Clin North Am. 2009 May;93(3):665-80. doi: 10.1016/j.mcna.2009.02.005.
3
Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) study.醛固酮与心肌梗死后的长期预后：法国全国性医院治疗、一年病情演变及伴或不伴Q波心肌梗死患者特征观察研究（OPERA研究）的一项子研究
Am Heart J. 2009 Apr;157(4):680-7. doi: 10.1016/j.ahj.2008.12.013. Epub 2009 Mar 17.
4
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.2009年重点更新：美国心脏病学会基金会/美国心脏协会成人心力衰竭诊断与管理指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告：与国际心肺移植学会合作制定。
Circulation. 2009 Apr 14;119(14):1977-2016. doi: 10.1161/CIRCULATIONAHA.109.192064. Epub 2009 Mar 26.
5
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.醛固酮拮抗剂预防慢性肾脏病进展的系统评价与荟萃分析
Clin J Am Soc Nephrol. 2009 Mar;4(3):542-51. doi: 10.2215/CJN.04750908. Epub 2009 Mar 4.
6
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.坎利酮对轻度慢性心力衰竭患者的抗重塑作用（心力衰竭区域干预研究）：最终结果
Eur J Heart Fail. 2009 Jan;11(1):68-76. doi: 10.1093/eurjhf/hfn015.
7
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.醛固酮阻断与左心室功能障碍：随机临床试验的系统评价
Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9.
8
Resistant hypertension: an overview of evaluation and treatment.顽固性高血压：评估与治疗概述
J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036.
9
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).依普利酮急性心肌梗死后心力衰竭疗效和生存研究（EPHESUS）中的血清钾与临床结局
Circulation. 2008 Oct 14;118(16):1643-50. doi: 10.1161/CIRCULATIONAHA.108.778811. Epub 2008 Sep 29.
10
A comparison of the aldosterone-blocking agents eplerenone and spironolactone.醛固酮阻断剂依普利酮和螺内酯的比较。
Clin Cardiol. 2008 Apr;31(4):153-8. doi: 10.1002/clc.20324.
Zotero 插件